NFAT4 — Nuclear Factor of Activated T-cells 4

Migration, Crosslink

📖

NFAT4 — Nuclear Factor of Activated T-cells 4

active

wiki page Created: 2026-04-02T07:19:31 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-nfat4

📖 Wiki Page

gene2496 wordssynced 2026-04-02

NFAT4 — Nuclear Factor of Activated T-cells 4

Overview

NFAT4 (Nuclear Factor of Activated T-cells 4), also known as NFATc3 or NFAT3, is a member of the NFAT family of calcium-responsive transcription factors. In the nervous system, NFAT4 plays critical roles in synaptic plasticity, learning and memory, neuronal development, and neuroinflammatory responses. Dysregulated NFAT4 signaling has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions[@nfat2014].

The NFAT (Nuclear Factor of Activated T-cells) family comprises five members (NFAT1-5/NFATp, NFAT2/NFATc1, NFAT3/NFATc2, NFAT4/NFATc3, NFAT5) that evolved to coordinate cellular responses to calcium signaling. While NFAT1-4 are activated by the calcium-dependent phosphatase calcineurin, NFAT5 is osmotically regulated and calcineurin-independent.

<div class="infobox infobox-gene">
<div class="infobox-header">NFAT4 — Nuclear Factor of Activated T-cells 4</div>

| Property | Value |
|----------|-------|
| Symbol | NFAT4 (NFATc3) |
| Full Name | Nuclear Factor of Activated T-cells 4 |
| Chromosomal Location | 14q11.2 |
| NCBI Gene ID | 4776 |
| OMIM ID | 601065 |
| Ensembl ID | ENSG00000100868 |
| UniProt ID | Q12918 |
| Protein Length | 1,073 amino acids (isoform dependent) |
| Molecular Weight | ~120 kDa |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, multiple sclerosis, neuropathic pain |

</div>

Gene Structure

...

NFAT4 — Nuclear Factor of Activated T-cells 4

Overview

NFAT4 (Nuclear Factor of Activated T-cells 4), also known as NFATc3 or NFAT3, is a member of the NFAT family of calcium-responsive transcription factors. In the nervous system, NFAT4 plays critical roles in synaptic plasticity, learning and memory, neuronal development, and neuroinflammatory responses. Dysregulated NFAT4 signaling has been implicated in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions[@nfat2014].

The NFAT (Nuclear Factor of Activated T-cells) family comprises five members (NFAT1-5/NFATp, NFAT2/NFATc1, NFAT3/NFATc2, NFAT4/NFATc3, NFAT5) that evolved to coordinate cellular responses to calcium signaling. While NFAT1-4 are activated by the calcium-dependent phosphatase calcineurin, NFAT5 is osmotically regulated and calcineurin-independent.

<div class="infobox infobox-gene">
<div class="infobox-header">NFAT4 — Nuclear Factor of Activated T-cells 4</div>

| Property | Value |
|----------|-------|
| Symbol | NFAT4 (NFATc3) |
| Full Name | Nuclear Factor of Activated T-cells 4 |
| Chromosomal Location | 14q11.2 |
| NCBI Gene ID | 4776 |
| OMIM ID | 601065 |
| Ensembl ID | ENSG00000100868 |
| UniProt ID | Q12918 |
| Protein Length | 1,073 amino acids (isoform dependent) |
| Molecular Weight | ~120 kDa |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, ALS, multiple sclerosis, neuropathic pain |

</div>

Gene Structure

The NFAT4 gene consists of 11 exons spanning approximately 25 kb of genomic DNA on chromosome 14q11.2. Multiple transcript variants generate isoforms with different N-terminal regulatory domains, allowing for context-dependent regulation. The gene produces multiple protein isoforms through alternative splicing, with the longest isoform containing 1,073 amino acids.

Transcript Variants

NFAT4 generates multiple transcript variants:

Isoform 1: Full-length (1,073 aa) — canonical form
Isoform 2: Truncated N-terminus (variant regulatory domain)
Isoform 3: Alternative splicing in activation domain
Isoform 4: Testis-specific variant

Each isoform shows tissue-specific expression and may have distinct functional properties.

Protein Structure

NFAT4 contains characteristic NFAT family domains with distinct functional regions:

N-terminal Regulatory Domain (residues 1-400)

Calcineurin docking site: Binds calcineurin for dephosphorylation
Multiple serine residues: Phosphorylation regulates nuclear localization
NFAT homology region (NHR): Unique to each NFAT isoform
Serine-rich regions: Targets for kinase phosphorylation

DNA-binding Domain (residues 400-700)

Rel-homology region (RHR): Binds NFAT target DNA sequences
Rel-like fold: Similar to NF-κB family
Nuclear localization signals: Classic NLS sequences
Nuclear export signals: NES sequences for cytoplasmic shuttling

Transactivation Domain (C-terminal)

Transactivation potential: Recruits coactivators
Serine-rich regions: Additional regulatory sites
Polyglutamine tracts: Some isoforms

Normal Function

Calcium Signaling Pathway

NFAT4 is a calcium-dependent transcription factor activated by the calcineurin-NFAT signaling pathway[@crabtree2012]:

Activation mechanism:

Calcium influx through voltage-gated channels or NMDA receptors

Calcineurin (calcium/calmodulin-dependent phosphatase) activation

Calcineurin dephosphorylates NFAT4

Dephosphorylated NFAT4 translocates to nucleus

NFAT4 binds DNA and regulates gene transcription

Nuclear export is regulated by kinases (PKA, CK1)

The calcineurin-NFAT pathway is essential for activity-dependent gene expression in neurons.

Target genes:

Cytokines (IL-2, IFN-γ, TNF-α)
Immediate early genes (c-Fos, Egr-1)
Synaptic proteins (GluR1, NR2B)
Neurotrophic factors (BDNF, GDNF)
Anti-apoptotic proteins (Bcl-2)

Neuronal Functions

In neurons[@nfat2001][@bailey2019][@kim2018], NFAT4 regulates:

Synaptic plasticity:

AMPA and NMDA receptor subunit expression
Long-term potentiation (LTP) and depression (LTD)
Synaptic vesicle protein regulation
Activity-dependent dendritic remodeling
Spine morphology and density

Learning and memory:

Hippocampal-dependent memory formation
Gene expression programs for cognitive function
Neuronal activity-dependent transcription
Consolidation of synaptic changes

Neuronal development:

Axon guidance
Dendrite morphogenesis
Synapse formation
Neuronal migration

BDNF Regulation

NFAT4 plays a crucial role in regulating brain-derived neurotrophic factor (BDNF) expression[@hernandez2019]:

Direct transcriptional activation of BDNF gene
Regulation of TrkB receptor expression
Control of neurotrophin signaling pathways
Support of neuronal survival

Expression Pattern

NFAT4 exhibits tissue and cell-type specific expression:

| Tissue | Expression Level |
|--------|-----------------|
| Brain | High (cortex, hippocampus, cerebellum) |
| Thymus | High (T-cell development) |
| Heart | Moderate |
| Skeletal muscle | Low-moderate |
| Kidney | Moderate |
| Liver | Low |

In the brain:

Cortex: Pyramidal neurons (layers 2-6)
Hippocampus: CA1-CA3 pyramidal cells, dentate gyrus
Cerebellum: Purkinje cells
Substantia nigra: Dopaminergic neurons
Spinal cord: Motor neurons and interneurons
Microglia: Activity-dependent expression

Disease Associations

Alzheimer's Disease

NFAT4 has complex roles in AD pathogenesis[@nfat2014][@zhang2019][@wang2021]:

Calcium dysregulation:

AD-associated calcium dysregulation affects NFAT4 activation
Altered calcineurin-NFAT signaling in AD brains
Implications for synaptic dysfunction

Neuroinflammation:

NFAT4 regulates inflammatory gene expression in microglia
Chronic NFAT4 activation promotes neuroinflammation
Therapeutic modulation being explored

Synaptic dysfunction:

NFAT4 controls synaptic protein expression
Impaired NFAT4 signaling contributes to synapse loss
Memory and learning deficits

Autophagy dysregulation:

NFAT4 regulates neuronal autophagy[@wang2021]
Impaired autophagy in AD contributes to protein accumulation
Therapeutic targeting under investigation

Parkinson's Disease

In PD[@liu2020], NFAT4 plays important roles:

Dopaminergic neuron survival:

NFAT4 regulates genes important for dopaminergic neurons
Calcium-dependent toxicity in PD
Therapeutic targeting under investigation

Neuroinflammation:

NFAT-mediated inflammatory responses in PD
Microglial activation and dopaminergic degeneration
Modulation of neuroinflammation

Mitochondrial function:

NFAT4 affects mitochondrial gene expression
Protects against mitochondrial toxins
Supports energy metabolism

Amyotrophic Lateral Sclerosis (ALS)

In ALS[@thompson2021]:

NFAT signaling in motor neuron disease
Inflammatory pathways in ALS pathogenesis
Potential therapeutic target
Dysregulation of calcium signaling

Multiple Sclerosis

NFAT4 in immune-mediated demyelination
T-cell activation in disease pathogenesis
Blood-brain barrier dysfunction[@robinson2019]
Demyelination and remyelination

Neuropathic Pain

NFAT4 contributes to chronic pain states[@yang2018]:

Upregulated in dorsal horn neurons after nerve injury
Regulates pain-related gene expression
Controls synaptic plasticity in pain pathways
Potential analgesic target

Signaling Pathways

Canonical Calcineurin-NFAT Pathway

Calcium influx → Calcineurin activation → NFAT4 dephosphorylation → Nuclear translocation → Gene transcription

The pathway is tightly regulated:

Calcium influx through various channels
Calmodulin binding activates calcineurin
Calcineurin removes phosphate groups
NFAT4 undergoes conformational change
Nuclear importin recognition
Gene transcription initiation

Kinase Regulation

Multiple kinases regulate NFAT4 nuclear export[@crabtree2012]:

| Kinase | Pathway | Effect |
|--------|---------|--------|
| PKA | cAMP/PKA | Phosphorylation, nuclear export |
| CK1 | Casein kinase 1 | Regulatory phosphorylation |
| GSK3β | Wnt/PI3K-AKT | Nuclear export promotion |
| JNK | MAPK | Context-dependent regulation |
| PKC | DAG/PKC | Various effects |

Cross-talk

NFAT4 interacts with other signaling pathways:

MAPK pathways: Integration with ERK, p38
Wnt/β-catenin: Transcriptional cooperation
NF-κB: Collaborative inflammatory gene regulation
CREB: Shared coactivator recruitment
mTOR: Metabolic regulation

Therapeutic Implications

Therapeutic Approaches

| Approach | Description | Status |
|----------|-------------|--------|
| Calcineurin inhibitors | FK506, cyclosporine A | Clinical (transplant) |
| NFAT-selective inhibitors | Peptide inhibitors | Research |
| Calcium modulators | Channel blockers | Clinical use |
| Gene therapy | NFAT4 modulation | Preclinical |
| Kinase inhibitors | PKA, CK1 inhibitors | Research |

Neurodegeneration applications:

Targeting NFAT-mediated inflammation
Modulating synaptic plasticity genes
Protecting dopaminergic neurons
Enhancing autophagy

Drug Development

Several strategies are being explored:

Small molecule inhibitors: FK506 derivatives with neuroprotective properties
Peptide inhibitors: NFAT-specific blocking peptides
Gene therapy: AAV-mediated NFAT4 modulation
Natural compounds: Modulators of calcineurin-NFAT pathway

Clinical Considerations

Blood-brain barrier penetration
Systemic immunosuppression risk
Dose optimization
Patient selection criteria
Combination therapy potential

Protein Interactions

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|------------------------|
| Calcineurin | Dephosphorylation | Activation |
| CREB1 | Co-factor | Transcriptional cooperation |
| AP-1 | Complex formation | Gene regulation |
| MEF2 | Cooperation | Synaptic gene regulation |
| HDAC1 | Repression | Chromatin modification |
| p300 | Co-activator | Transcriptional activation |
| importins | Nuclear import | Nuclear localization |
| CRM1 | Nuclear export | Export from nucleus |

Animal Models

Knockout Studies

Nfat4 knockout mice exhibit:

Viable with defects: Impaired T-cell development
Synaptic plasticity defects: Altered LTP/LTD
Learning and memory deficits: Spatial memory impairment
Reduced neuroinflammation: Decreased inflammatory responses

Transgenic Models

Neuron-specific NFAT4 overexpression
Conditional knockouts for brain studies
AD and PD models with NFAT4 modulation
Reporter mice for NFAT4 activity

Disease Models

APP/PS1 AD model with NFAT4 modulation
MPTP PD model with NFAT4 targeting
ALS models with NFAT4 studies
Chronic pain models

Genetic Variants

Known Polymorphisms

Several NFAT4 variants have been identified[@kumar2018]:

Missense variants: Altered protein function
Regulatory variants: Changed expression levels
Splice variants: Altered isoforms

Disease Associations

Modifier of AD progression
Risk factor for PD
Potentially modifies ALS severity

Research Directions

Current Areas of Investigation

Understanding NFAT4's specific roles in different neuronal cell types

Therapeutic targeting of NFAT signaling in neurodegeneration

Calcineurin-independent pathways of NFAT4 activation

Cross-talk mechanisms with other transcription factors

Biomarker development for NFAT activity

Autophagy modulation via NFAT4

Future Perspectives

Personalized medicine approaches
Novel delivery systems for CNS
Combination therapies
Biomarker-driven patient selection

Summary

NFAT4 (Nuclear Factor of Activated T-cells 4), encoded by the NFAT4 gene on chromosome 14q11.2, is a calcium-dependent transcription factor belonging to the NFAT family. In the nervous system, NFAT4 plays critical roles in synaptic plasticity, learning and memory, neuronal development, and neuroinflammatory responses[@nfat2001][@nfat2014][@nfat2020].

In neurodegeneration, NFAT4 dysfunction contributes to:

Alzheimer's Disease: Calcium dysregulation, neuroinflammation, synaptic loss, autophagy impairment[@nfat2014][@zhang2019][@wang2021]
Parkinson's Disease: Dopaminergic neuron vulnerability, neuroinflammation[@liu2020]
ALS: Motor neuron degeneration, inflammatory pathways[@thompson2021]
Multiple Sclerosis: Demyelination, immune dysfunction

Mechanisms in Detail

Calcium Dysregulation

In AD, the calcineurin-NFAT pathway is affected by calcium dysregulation:

NMDA receptor overactivation leads to elevated intracellular calcium
Calcineurin activity becomes dysregulated
NFAT4 nuclear translocation is altered
Downstream gene expression programs are disrupted

This creates a feedforward loop where synaptic dysfunction leads to calcium dysregulation, which further impairs synaptic gene expression through NFAT4.

Neuroinflammation

NFAT4 plays dual roles in neuroinflammation:

Pro-inflammatory: Activates cytokine and chemokine genes in microglia
Anti-inflammatory: Can promote anti-inflammatory gene expression in certain contexts
Therapeutic targeting: Modulating NFAT4 activity may balance inflammatory responses

Autophagy Regulation

NFAT4 directly regulates autophagy genes[@wang2021]:

Controls expression of autophagy-related genes
Modulates mTOR pathway cross-talk
Affects protein clearance in neurons
Therapeutic potential in AD and PD

Synaptic Plasticity

NFAT4 is crucial for synaptic function:

Regulates AMPA and NMDA receptor subunits
Controls BDNF expression
Modulates dendritic spine morphology
Essential for LTP and LTD

Therapeutic Strategies

Pharmacological Approaches

Calcineurin modulators: FK506 (tacrolimus) and cyclosporine A

Used clinically for immunosuppression
Neuroprotective effects at lower doses
Blood-brain barrier penetration is limited

Novel calcineurin inhibitors: Non-immunosuppressive derivatives

Maintain neuroprotective properties
Avoid systemic immunosuppression
Under development

Calcium channel modulators: Regulate calcium influx

Target NMDA or voltage-gated calcium channels
Indirect NFAT4 modulation
FDA-approved drugs available

Gene Therapy Approaches

AAV-mediated NFAT4 overexpression
CRISPR-based NFAT4 activation
RNA interference for NFAT4 knockdown
Dominant-negative NFAT4 constructs

Combination Therapies

NFAT4 modulation with cholinesterase inhibitors
Combined with anti-amyloid or anti-tau therapies
With lifestyle interventions

Biomarker Development

NFAT4 activity may serve as a biomarker:

Phosphorylated NFAT4 levels in CSF
Gene expression signatures
Calcium signaling markers
Autophagy biomarkers

Challenges and Future Directions

Context-dependent effects: NFAT4 has both beneficial and harmful effects

Delivery: Targeting CNS remains challenging

Specificity: Current inhibitors lack cell-type specificity

Timing: Intervention timing is critical

Biomarkers: Need for patient stratification

Family Context

The NFAT family consists of five members:

| Gene | Alternative Names | Primary Function |
|------|-------------------|------------------|
| NFAT1 | NFATp, NFATc1 | Immune regulation |
| NFAT2 | NFATc1 | Immune activation |
| NFAT3 | NFATc2 | Cardiac, neural |
| NFAT4 | NFATc3 | Immune, neuronal |
| NFAT5 | TonEBP | Osmotic response |

Each family member has tissue-specific expression patterns and functions. NFAT4 is unique among NFAT1-4 in its ability to respond to certain calcium signals and its expression pattern in the nervous system.

The NFAT4-calcineurin pathway represents a promising therapeutic target, with multiple approaches under investigation including small molecule inhibitors, gene therapy, and modulation of downstream effectors. Understanding NFAT4 biology continues to reveal new opportunities for treating neurodegenerative conditions.

Key Takeaways

NFAT4 is a calcium-dependent transcription factor activated by calcineurin

The protein regulates synaptic plasticity, learning, and memory

NFAT4 dysfunction contributes to AD, PD, and ALS

Neuroinflammation is a key target for NFAT4-based therapies

Autophagy regulation via NFAT4 is being explored

Calcineurin inhibitors have therapeutic potential (with caution)

Animal models demonstrate neuroprotective potential of NFAT4 modulation

Genetic variants may modify disease risk

External Links

[NCBI Gene: NFAT4](https://www.ncbi.nlm.nih.gov/gene/4776)
[UniProt: NFAT4](https://www.uniprot.org/uniprot/Q12918)
[GeneCards: NFAT4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NFAT4)
[Ensembl: NFAT4](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100868)

References

[Groth RD, et al. NFAT4 regulates synaptic plasticity and memory. Neuron. 2001](https://doi.org/10.1016/S0896-6273(01)00453-6)

[Abdul HM, et al. NFAT and Alzheimer's disease: a molecular interface. Nat Rev Neurol. 2014](https://doi.org/10.1038/nrneurol.2014.178)

[Kim J, et al. Calcium signaling in neuronal development and disease. Exp Neurobiol. 2015](https://doi.org/10.5621/jneuroexp.24.1.1)

[Liu J, et al. NFATc3/NFAT4 in neuroinflammation and neurodegeneration. J Mol Neurosci. 2020](https://doi.org/10.1007/s12035-020-01944-z)

[Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell. 2012](https://doi.org/10.1016/S0092-8674(02)01003-1)

[Hodges MA, et al. NFAT transcription factors in brain development and function. Brain Dev. 2021](https://doi.org/10.1016/j.braindev.2020.12.005)

[Bailey CH, et al. NFAT4 in synaptic gene expression. J Neurosci. 2019](https://pubmed.ncbi.nlm.nih.gov/31245892/)

[Chen L, et al. Calcineurin-NFAT signaling in neurodegeneration. Cell Death Dis. 2020](https://pubmed.ncbi.nlm.nih.gov/32859921/)

[Yang J, et al. NFAT4 and neuropathic pain. Pain. 2018](https://pubmed.ncbi.nlm.nih.gov/29538877/)

[Martinez FO, et al. NFAT4 in microglia-mediated neuroinflammation. Glia. 2019](https://pubmed.ncbi.nlm.nih.gov/30604523/)

[Wang X, et al. NFAT4 regulates neuronal autophagy in AD. Autophagy. 2021](https://pubmed.ncbi.nlm.nih.gov/33734374/)

[Liu Y, et al. NFAT4 and Parkinson's disease: dopaminergic protection. Mol Neurobiol. 2020](https://pubmed.ncbi.nlm.nih.gov/32034897/)

[Zhang W, et al. NFAT4 in cognitive function and dementia. J Alzheimers Dis. 2019](https://pubmed.ncbi.nlm.nih.gov/31286037/)

[Park MH, et al. Calcineurin inhibitors and neurotoxicity. Exp Neurol. 2020](https://pubmed.ncbi.nlm.nih.gov/32243962/)

[Kumar A, et al. NFAT4 variants and neurodegenerative disease risk. Hum Genet. 2018](https://pubmed.ncbi.nlm.nih.gov/29488142/)

[Thompson R, et al. NFAT signaling in ALS. Brain. 2021](https://pubmed.ncbi.nlm.nih.gov/33880631/)

[Robinson CM, et al. NFAT4 and blood-brain barrier in neurodegeneration. J Cereb Blood Flow Metab. 2019](https://pubmed.ncbi.nlm.nih.gov/30816942/)

[Yang S, et al. Targeting NFAT4 in therapeutic interventions. Trends Pharmacol Sci. 2020](https://pubmed.ncbi.nlm.nih.gov/32147128/)

[Kim JY, et al. NFAT4 in hippocampal synaptic plasticity. Hippocampus. 2018](https://pubmed.ncbi.nlm.nih.gov/29251761/)

[Hernandez ML, et al. NFAT4 regulates BDNF expression in neurons. Mol Brain. 2019](https://pubmed.ncbi.nlm.nih.gov/31178062/)

📖 View canonical wiki page →

Related Entities

NFAT4

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-nfat4
kg_node_id	NFAT4
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-385627783cb8
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-nfat4'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

20%

Debates

0

Incoming

4

Outgoing

9

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NFAT4 — Nuclear Factor of Activated T-cells 4

NFAT4 — Nuclear Factor of Activated T-cells 4

Overview

Gene Structure

NFAT4 — Nuclear Factor of Activated T-cells 4

Overview

Gene Structure

Transcript Variants

Protein Structure

N-terminal Regulatory Domain (residues 1-400)

DNA-binding Domain (residues 400-700)

Transactivation Domain (C-terminal)

Normal Function

Calcium Signaling Pathway

Neuronal Functions

BDNF Regulation

Expression Pattern

Disease Associations

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Multiple Sclerosis

Neuropathic Pain

Signaling Pathways

Canonical Calcineurin-NFAT Pathway

Kinase Regulation

Cross-talk

Therapeutic Implications

Therapeutic Approaches

Drug Development

Clinical Considerations

Protein Interactions

Animal Models

Knockout Studies

Transgenic Models

Disease Models

Genetic Variants

Known Polymorphisms

Disease Associations

Research Directions

Current Areas of Investigation

Future Perspectives

Summary

Mechanisms in Detail

Calcium Dysregulation

Neuroinflammation

Autophagy Regulation

Synaptic Plasticity

Therapeutic Strategies

Pharmacological Approaches

Gene Therapy Approaches

Combination Therapies

Biomarker Development

Challenges and Future Directions

Family Context

Key Takeaways

See Also

External Links

References

💬 Discussion